Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to register a CAGR of 14.7%.
Key participants are involved in R&D of genetic and proteomic sequencing to improve DNA, RNA sequencing capabilities to further decrease the costs of genome sequencing. The development of next-generation sequencing technologies is projected to boost the bioinformatics industry during the forecast period.
The report "Global Bioinformatics Platform Market, By Platform Type (Sequence Analysis Platform, Sequence Alignment Platform, Structural & Functional Analysis Platforms, and Others), By Application (Drug Development, Molecular Genomics, Gene Therapy, Personalized Medicines, and Others), By End-user (Academic & Research Institutes, Contract Research Organizations, and Biotechnology Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.
Key Highlights:
- In January 2002, Illumina announced a New Sequencing System, partnership with Roche and Software suite to accelerate the adoption of genomics.
- In November 2019, QIAGEN N.V. announced an agreement with LabCorp to extend its current QIAGEN Clinical Insights (QCI) license with QIAGEN’s Human Gene Mutation Database (HGMD) of human genetic variants, the world’s largest database of inherited disease mutations. This agreement builds on the existing seven-year relationship between the two companies to develop, introduce, and support new diagnostic tests. LabCorp will use HGMD across its network of laboratories to improve the identification and interpretation of genetic variants within inherited diseases.
Request Sample PDF of the Business Intelligence Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4343
Analyst View:
A growing number of advanced systems and rising demand for advanced technologies to understand the characteristics of molecular biology are likely to propel the bioinformatics platforms market over the forecast period. Additionally, the introduction of readily and user-friendly bioinformatics software such as RasMol, BALL, AUTODOCK, Bioclipse is also driving growth of the target market. Further, rising market usage of these tools for effective and accurate analysis of biomarkers discovery programs that aid in toxicity detection throughout the initial stage of the drug development process are projected to surge the industry growth in the coming period.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Bioinformatics Platform Market”, By Platform Type (Sequence Analysis Platform, Sequence Alignment Platform, Structural & Functional Analysis Platforms, and Others), By Application (Drug Development, Molecular Genomics, Gene Therapy, Personalized Medicines, and Others), By End-user (Academic & Research Institutes, Contract Research Organizations, and Biotechnology Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029
Ask for Discount on the Current Price @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/4343
Key Market Insights from the report:
The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to register a CAGR of 14.7%. The market report has been segmented on the basis of platform type, application, end-user, and region.
- By platform type, the global bioinformatics platform market is segmented into a sequence analysis platform, sequence alignment platform, structural & functional analysis platforms, and others.
- By application, the target market is segmented into drug development, molecular genomics, gene therapy, personalized medicines, and others.
- By the end-user, the target market is segmented into academic & research institutes, contract research organizations, and biotechnology organizations.
- By region, North America is the worldwide leader in the bioinformatics platform market, due to the growing application of bioinformatics in both pharmaceutical and biotechnological research, followed by Europe and Asia. The market is increasing steadily mainly in the U.S. and Europe.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Bioinformatics-Platform-Market-4343
Competitive Landscape:
The prominent player operating in the global bioinformatics platform market includes Illumina Inc., Sophia Genetics, Qiagen, Dassault Systems, ID Business Solutions, Agilent Technologies, Genologics Life Sciences Software Inc., DNASTAR, Wuxi NextCODE, and BGI.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
- Explains an overview of the product portfolio, including product development, planning, and positioning
- Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
- Detailed analysis of the market revenue over the forecasted period.
- Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
- Study on the segments that are anticipated to dominate the market.
- Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered
- Introduction
- Study Deliverables
- Study Assumptions
- Scope of the Study
- Research Methodology
- Executive Summary
- Opportunity Map Analysis
- Market at Glance
- Market Share (%) and BPS Analysis, by Region
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Investment Analysis
- Competitive Analysis
Browse Related Reports: